Apoptosis in liver transplantation: A mechanism contributing to immune modulation, preservation injury, neoplasia, and viral disease

Liver Transplantation and Surgery

Volumn 4, Issue 1, 1998, Pages 42-50

  Patel, T ^a   Gores, G J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CYCLOSPORIN A; FAS ANTIGEN; FAS LIGAND; GLUCOCORTICOID; GRANZYME A; GRANZYME B; PERFORIN; PROTEIN BCL 2; TACROLIMUS;

APOPTOSIS; CYTOMEGALOVIRUS; CYTOTOXIC T LYMPHOCYTE; EPSTEIN BARR VIRUS; GRAFT PRESERVATION; GRAFT REJECTION; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOPATHOGENESIS; IMMUNOSUPPRESSIVE TREATMENT; LIVER ISCHEMIA; LIVER TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; T LYMPHOCYTE ACTIVATION; TARGET CELL DESTRUCTION; VIRUS INFECTION;

EID: 0031962520     PISSN: 10743022     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.500040106     Document Type: Review

References (55)

1. 1 Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide‐ranging implications in tissue kinetics. Br J Cancer 1972 ; 26: 239–257. MEDLINE
2. 2 Cidlowski JA, King KL, Evans‐Storms RB, Montague JW, Bortner CD, Hughes FM. The biochemistry and molecular biology of glucocorticoid‐induced apoptosis in the immune system. Recent Prog Horm Res 1996 ; 51: 457–490. MEDLINE
3. 3 Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995 ; 267: 1456–1462. MEDLINE
4. 4 Vaux DL, Strasser A. The molecular biology of apoptosis. Proc Natl Acad Sci USA 1996 ; 93: 2239–2244. MEDLINE
5. 5 Hale AJ, Smith CA, Sutherland LC, Stoneman VE, Longthorne V, Culhane AC, et al. Apoptosis: molecular regulation of cell death. Eur J Biochem 1996 ; 237: 884. MEDLINE
6. 6 White E. Life, death, and the pursuit of apoptosis. Genes Dev 1996 ; 10: 1–15. MEDLINE
7. 7 Smith CA, Farrah T, Goodwin RG. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 1994 ; 76: 959–962. MEDLINE
8. 8 Nishimura Y, Ishii A, Kobayashi Y, Yamasaki Y, Yonehara S. Expression and function of mouse Fas antigen on immature and mature T cells. J Immunol 1995 ; 154: 4395–4403. MEDLINE
9. 9 Watanabe‐Fukunaga R, Brannan CI, Itoh N, Yonehara S, Copeland NG, Jenkins NA, et al. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J Immunol 1992 ; 148: 1274–1279. MEDLINE
10. 10 van Parijs L, Abbas A. Role of Fas‐mediated cell death in the regulation of immune responses. Curr Opin Immunol 1996 ; 8: 355–361. MEDLINE
11. 11 Suda T, Takahashi T, Golstein P, Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 1993 ; 75: 1169–1178. MEDLINE
12. 12 Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl‐2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993 ; 74: 609–619. MEDLINE
13. 13 Boise LH, Gonzalez‐Garcia M, Postema CE, Ding L, Lindsten T, Turka LA, et al. bcl‐x, a bcl‐2‐related gene that functions as a dominant regulator of apoptotic cell death. Cell 1993 ; 74: 597–608. MEDLINE
14. 14 Cohen JJ, Duke RC, Fadok VA, Sellins KS. Apoptosis and programmed cell death in immunity. Annu Rev Immunol 1992 ; 10: 267–293. MEDLINE
15. 15 Ashwell JD. Lymphocyte programmed cell death. In: Snow, EC eds. Handbook of B and T lymphocytes. San Diego, CA: Academic. 1994 ; 63–89.
16. 16 Murphy KM, Heimberger AB, Loh DY. Induction by antigen of intrathymic apoptosis of CD4+CD8+TCRlo thymocytes in vivo. Science 1990 ; 250: 1720–1723. MEDLINE
17. 17 Kisielow P, Bluthmann H, Staerz UD, Steinmetz M, von Boehmer H. Tolerance in T‐cell–receptor transgenic mice involves deletion of nonmature CD4+8+ thymocytes. Nature 1988 ; 333: 742–746. MEDLINE
18. 18 Kappler JW, Roehm N, Marrack P. T cell tolerance by clonal elimination in the thymus. Cell 1987 ; 49: 273–280. MEDLINE
19. 19 Kabelitz D, Pohl T, Pechhold K. T cell apoptosis triggered via the CD3/T cell receptor complex and alternative activation pathways. Curr Top Microbiol Immunol 1995 ; 200: 1–14. MEDLINE
20. 20 Boise LH, Noel PJ, Thompson CB. CD28 and apoptosis. Curr Opin Immunol 1995 ; 7: 620–625. MEDLINE
21. 21 Lenschow DJ, Zeng Y, Hathcock KS, Zuckerman LA, Freeman G, Thistlethwaite JR, et al. Inhibition of transplant rejection following treatment with anti‐B7–2 and anti‐B7–1 antibodies. Transplantation 1995 ; 60: 1171–1178. MEDLINE
22. 22 Turka LA, Linsley PS, Lin H, Brady W, Leiden JM, Wei RQ, et al. T‐cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. Proc Natl Acad Sci USA 1992 ; 89: 11102–11105. MEDLINE
23. 23 Boise LH, Minn AJ, Noel PJ, June CH, Accavitti MA, Lindsten T, et al. CD28 costimulation can promote T cell survival by enhancing the expression of Bcl‐XL. Immunity 1995 ; 3: 87–98. MEDLINE
24. 24 Walunas TL, Lenschow DJ, Bakker CY, Linsley PS, Freeman GJ, Green JM, et al. CTLA‐4 can function as a negative regulator of T cell activation. Immunity 1994 ; 1: 405–413. MEDLINE
25. 25 Gribben JG, Freeman GJ, Boussiotis VA, Rennert P, Jellis CL, Greenfield E, et al. CTLA4 mediates antigen‐specific apoptosis of human T cells. Proc Natl Acad Sci USA 1995 ; 92: 811–815. MEDLINE
26. 26 Huang L, Soldevila G, Leeker M, Flavell R, Crispe IN. The liver eliminates T cells undergoing antigen‐triggered apoptosis in vivo. Immunity 1994 ; 1: 741–749. MEDLINE
27. 27 Berke G. The CTL's kiss of death. Cell 1995 ; 81: 9–12. MEDLINE
28. 28 Kamada N. Experimental liver transplantation. Boca Raton, FL: CRC. 1988 ;.
29. 29 Garnier H, Clot JP, Bertrand M, Camplez P, Kunlin A, Gorin JP, et al. [Liver transplantation in the pig: surgical approach] [French]. C R Acad Sci Hebd Seances Acad Sci D 1965 ; 260: 5621–5623. MEDLINE
30. 30 Wood K, Farges O. Tolerance. In: Neuberger, J Adams, D eds. Immunology of liver transplantation. London: Edward Arnold. 1993 ; 139–151.
31. 31 Bellgrau D, Gold D, Selawry H, Moore J, Franzusoff A, Duke RC. A role for CD95 ligand in preventing graft rejection [see comments]. Nature 1995 ; 377: 630–632. MEDLINE
32. 32 Green DR, Ware CF. Fas‐ligand—‐privilege and peril. Proc Natl Acad Sci USA 1997 ; 94: 5986–5990. MEDLINE
33. 33 Zavazava N, Kronke M. Soluble HLA class I molecules induce apoptosis in alloreactive cytotoxic T lymphocytes. Nat Med 1996 ; 2: 1005–1010. MEDLINE
34. 34 Wiederrecht G, Lam E, Hung S, Martin M, Sigal N. The mechanism of action of FK‐506 and cyclosporin A. Ann NY Acad Sci 1993 ; 696: 9–19. MEDLINE
35. 35 Fruman DA, Mather PE, Burakoff SJ, Bierer BE. Correlation of calcineurin phosphatase activity and programmed cell death in murine T cell hybridomas. Eur J Immunol 1992 ; 22: 2513–2517. MEDLINE
36. 36 Prud'homme GJ, Vanier LE, Bocarro DC, Ste‐Croix H. Effects of cyclosporin A, rapamycin, and FK520 on peripheral T‐cell deletion and anergy. Cell Immunol 1995 ; 164: 47–56. MEDLINE
37. 37 Yazdanbakhsh K, Choi JW, Li Y, Lau LF, Choi Y. Cyclosporin A blocks apoptosis by inhibiting the DNA binding activity of the transcription factor Nur77. Proc Natl Acad Sci USA 1995 ; 92: 437–441. MEDLINE
38. 38 Battersby C, Egerton WS, Balderson G, Kerr JF, Burnett W. Another look at rejection in pig liver homografts. Surgery 1974 ; 76: 617–623. MEDLINE
39. 39 Searle J, Kerr JF, Battersby C, Egerton WS, Balderson G, Burnett W. An electron microscopic study of the mode of donor cell death in unmodified rejection of pig liver allografts. Aust J Exp Biol Med Sci 1977 ; 55: 401–406. MEDLINE
40. 40 Krams SM, Egawa H, Quinn MB, Villanueva JC, Garcia‐Kennedy R, Martinez OM. Apoptosis as a mechanism of cell death in liver allograft rejection [see comments]. Transplantation 1995 ; 59: 621–625. MEDLINE
41. 41 Afford SC, Hubscher S, Strain AJ, Adams DH, Neuberger JM. Apoptosis in the human liver during allograft rejection and end‐stage liver disease. J Pathol 1995 ; 176: 373–380. MEDLINE
42. 42 Nawaz S, Fennell RH. Apoptosis of bile duct epithelial cells in hepatic allograft rejection. Histopathology 1994 ; 25: 137–142. MEDLINE
43. 43 Gapany C, Zhao M, Zimmermann A. The apoptosis protector, bcl‐2 protein, is downregulated in bile duct epithelial cells of human liver allografts. J Hepatol 1997 ; 26: 535–542. MEDLINE
44. 44 Afford S, Williams A, Fear J, Hubscher S, D'Silva M, Pirenne J, et al. A potential role for fas (CD95) and fas ligand (CD956) in liver allograft rejection following orthotopic liver transplantation. XVI International Congress of Transplantation Society, Barcelona 1996 ;.
45. 45 Krams SM, Egawa H, So S, Esquivel CO, Martinez OM. Involvement of the CD95 (Fas)/CD95L (Fas L) pathway in the response to alloantigen. XVI International Congress of Transplantation Society, Barcelona 1996 ;.
46. 46 Eberl T, Trieb K, Steger M, Ofner D, Gnaiger E, Grubek‐Lowenstein B, et al. Apoptosis as a possible mechanism of preservation‐induced endothelial cell damage. XVI International Congress of the Transplantation Society, Barcelona 1996 ;.
47. 47 Sasaki H, Matsuno T, Tanaka N, Haisa M, Yagi T, Saito S, et al. Activation of apoptosis during early phase of reperfusion after swine liver transplantation. XVI International Congress of the Transplantation Society, Barcelona 1996 ;.
48. 48 Chetty R, Biddolph SC, Kaklamanis L, Cary N, Stewart S, Giatromanolaki A, et al. EBV latent membrane protein (LMP‐1) and BCL‐2 protein expression in Reed‐Sternberg‐like cells in post‐transplant lymphoproliferative disorders. Histopathology 1996 ; 28: 257–260. MEDLINE
49. 49 Murray PG, Swinnen LJ, Constandinou CM, Pyle JM, Carr TJ, Hardwick JM, et al. BCL‐2 but not its Epstein‐Barr virus‐encoded homologue, BHRF1, is commonly expressed in posttransplantation lymphoproliferative disorders [see comments]. Blood 1996 ; 87: 706–711. MEDLINE
50. 50 Collins M. Potential roles of apoptosis in viral pathogenesis. Am J Respir Crit Care Med 1995 ; 152: S20–S24. MEDLINE
51. 51 Macen JL, Garner RS, Musy PY, Brooks MA, Turner PC, Moyer RW, et al. Differential inhibition of the Fas‐ and granule‐mediated cytolysis pathways by the orthopoxvirus cytokine response modifier A/SPI‐2 and SPI‐1 protein. Proc Natl Acad Sci USA 1996 ; 93: 9108–9113. MEDLINE
52. 52 Labalette M, Queyrel V, Masy E, Noel C, Pruvot FR, Dessaint JP. Implication of cyclosporine in up‐regulation of Bcl‐2 expression and maintenance of CD8 lymphocytosis in cytomegalovirus‐infected allograft recipients. Transplantation 1995 ; 59: 1714–1723. MEDLINE
53. 53 Patel T, Gores GJ. Apoptosis and hepatobiliary disease. Hepatology 1995 ; 21: 1725–1741. MEDLINE
54. 54 Mochizuki K, Hayashi N, Hiramatsu N. Fas antigen expression in liver tissues of patients with chronic hepatitis B. J Hepatol 1996 ; 24: 1–7. MEDLINE
55. 55 Ando K, Guidotti LG, Wirth S, Ishikawa T, Missale G, Moriyama T, et al. Class I‐restricted cytotoxic T lymphocytes are directly cytopathic for their target cells in vivo. J Immunol 1994 ; 152: 3245–3253. MEDLINE